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Background. Basic cell-penetrating peptides are potential vectors for therapeutic molecules and display antimicrobial activity.
The peptide-membrane contact is the first step of the sequential processes leading to peptide internalization and cell activity.
However, the molecular mechanisms involved in peptide-membrane interaction are not well understood and are frequently
controversial. Herein, we compared the membrane activities of six basic peptides with different size, charge density and
amphipaticity: Two cell-penetrating peptides (penetratin and R9), three amphipathic peptides and the neuromodulator
substance P. Methodology/Principal Findings. Experiments of X ray diffraction, video-microscopy of giant vesicles,
fluorescence spectroscopy, turbidimetry and calcein leakage from large vesicles are reported. Permeability and toxicity
experiments were performed on cultured cells. The peptides showed differences in bilayer thickness perturbations, vesicles
aggregation and local bending properties which form lipidic tubular structures. These structures invade the vesicle lumen in
the absence of exogenous energy. Conclusions/Significance. We showed that the degree of membrane permeabilization
with amphipathic peptides is dependent on both peptide size and hydrophobic nature of the residues. We propose a model for
peptide-induced membrane perturbations that explains the differences in peptide membrane activities and suggests the
existence of a facilitated ‘‘physical endocytosis,’’ which represents a new pathway for peptide cellular internalization.
Citation: Lamazie `re A, Burlina F, Wolf C, Chassaing G, Trugnan G, et al (2007) Non-Metabolic Membrane Tubulation and Permeability Induced by
Bioactive Peptides. PLoS ONE 2(2): e201. doi:10.1371/journal.pone.0000201
INTRODUCTION
Processes such as neuromodulation, toxicity, and cell communi-
cation can be regulated by natural peptides and protein basic
domains. This group encompass several hormones, and antibac-
terial peptides. Beside these peptides, many proteins have been
identified for their capacity to enter cells and reach the cytoplasm.
This includes proteins such as homeoproteins, Tat from HIV or
the Anthrax and Cholera toxins. The penetration of these proteins
into cells is mediated by the presence of basic domains termed
protein transduction domains. This has led to the development of
short cell-penetrating peptides (CPPs) which are able to enter
eukaryotic cells and carry bioactive molecules (for review see [1]).
Some of these CPPs also present antimicrobial properties [2,3].
Generally, the antimicrobial peptides (AMPs) corresponding to the
innate immune system are basic and are able to bind and strongly
destabilize membranes of bacteria. On the other hand, some
neuromodulator peptides possess a dual interaction mode with cells.
For example, Substance P (SP) binds to its specific membrane
receptor (NK1) and it also binds lipid monolayers due to its partial
penetrationinthelipiddomain[4].Moreover,SPhasbeenreported
to enter mast cells lacking the NK1 receptor [5]. The study of these
peptides activities is currently rising after the recent occurrence of
synthetic peptides designed to stimulate, penetrate and eventually
kill living cells. The synthetic peptides comprise peptides such as
polyarginine, polylysine or model amphipathic peptides (for review
see [1]). All of these peptides are potential therapeutic molecules for
the delivery of active molecules [6] and drugs.
These peptides (SP, CPPs, AMPs) share a strong basic character
and can be classified in two families: amphipathic and non-
amphipathic. The amphipathic character is either related to the
charge location in the primary sequence as for SP and the CPP
Pep-1 [7] or to the secondary structure (a-helix) as for the Model
Amphipathic Peptides [8]. Some amphipathic helical peptides are
able to form oligomers leading to an increase of the plasma
membrane permeability (‘‘pores’’). On prokaryotic cells, the
permeabilization by AMPs depends on various factors such as
peptide length, hydrophobicity and charged/hydrophobic surfaces
ratio. Two permeation mechanisms have been proposed so far: i)
the barrel-stave model in which the amphipathic peptides
aggregate and insert into the lipid bilayer forming a channel-like
transmembrane structure. ii) The toroidal model or detergent-like
mechanism which is more deleterious to the membrane structure.
The peptide interacts with the membrane surface and curves
strongly the bilayer so the pore is lined by headgroups associated
with peptides. In this case, short peptides not long enough to span
the membrane are able to form pores. [9–13].
By contrast, basic CPPs such as Tat, R9 or penetratin (pAntp)
do not exhibit any lytic activities on mammalian cells. Both AMP
and CPP membrane activities arereceptor-independent. The studies
of fluorescent CPPs on cultured cells have revealed that different
endocytic pathways contribute to the internalization of CPPs:
clathrin-independent endocytosis [14], the caveolae-mediated
endocytosis [15] or macropinocytosis [16]. In neurons, and in
contradiction with the endocytic hypothesis, penetratin internaliza-
tion was found to be energy-independent [17] (for review see [18]).
Penetratin adopts a partially amphipathic a-helical structure at
the membrane surface [19], which is shifted to a b-structure when
Academic Editor: Mark Isalan, Center for Genomic Regulation, Spain
Received December 5, 2006; Accepted January 18, 2007; Published February 14,
2007
Copyright:  2007 Lamaziere et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This work was supported by INSERM, ANR-PCV and ACI grants.
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: jayala@chusa.jussieu.
fr
PLoS ONE | www.plosone.org 1 February 2007 | Issue 2 | e201the peptide/lipid ratio increases [20,21]. The CPPs corresponding
to the helix III of different homeoproteins present variable
penetration efficiencies (‘‘snorkelling’’) in SDS micelles. Paradox-
ically, the peptide with the highest cellular uptake efficiency was
found to be the most superficial in SDS micelles [22]. Penetratin is
not internalized in phosphatidylcholine/phosphatidylglycerol
(PC/PG) Large Unilamellar Vesicles (LUVs) [23] however,
penetration increased in the presence of a transbilayer potential
[24]. The efficiencies of translocation depended on the lipid
composition. At membrane saturation concentrations Penetratin
and R8 provoked a weak leakage of calcein from PC/PG LUVs
[25,26].
The mechanisms of CPPs membrane translocation are still in
debate. Many models of CPPs were proposed explaining the
cellular uptake: direct membrane penetration, inverted micelle
formation [17], penetration by endocytosis [14], or macropinocy-
tosis [16]. The absence of molecular explanations for the role of
energy-independent steps in cell uptake results in controversial
data [18].
The first step of peptide-cell interaction involves the association
of the peptide with the phospholipid components of the outer
membrane leaflet. We have selected three different sorts of basic
peptides able to bind with negatively charged membranes: the
primary amphipathic peptide substance P (SP), the cell-penetrat-
ing peptides penetratin (pAntp) [27] and R9 [28] and three
secondary amphipathic peptides [29] (table 1 and figure 1). We
focus on the relationship between the total charge, length and
amphipathicity of these peptides and their effects on membranes.
The effects of peptides have been analyzed using small angle X ray
diffraction, microscopy of Giant Unilamellar Vesicles (GUVs),
experiments of calcein leakage from LUVs, turbidimetry and
tryptophan fluorescence. The permeability and the toxicity have
been analyzed on cell cultures. Depending on their charge and
amphipathic character these peptides induce different effects on
membrane bilayers including the formation of tubes and vesicles
adhesion and/or the formation of pores. Relationships have been
found between membrane aggregation and tube formation and
size of membrane pores and the nature of the hydrophobic
residues. The deformations of PC/PG bilayers on GUVs leading
to tubes and vesicles may be stabilized by the formation of
peptides/lipids complexes. These physical ‘‘endocytosis-like’’
deformations may represent a new energy-independent pathway
for the cellular uptake of cell penetrating peptides, transcription
factors containing protein transduction domains and toxins.
Table 1. Sequences and physicochemical features of peptides.
..................................................................................................................................................
Name Sequence Length Charge
a Amphipathic
b
Penetratin (pAntp) RQIKIWFQNRRMKWKK-NH2 16 7 no
Polyarginine (R9) RRRRRRRRR-NH2 91 0 n o
RW9 RRWWRRWRR-NH2 9 7 yes
RW16 RRWRRWWRRWWRRWRR-Bi 16 10 yes
RL16 RRLRRLLRRLLRRLRR-Bi 16 10 yes
Substance-P (SP) RPKPQQFFGLM-NH2 11 3 no
a)Net theoretical positive charge at pH 7. (R9, RW9 and SP contained a free N-terminal amino group. RW16 and RL16 contained a biotin (Bi) on N-terminus. Both
biotinylated and acetylated penetratin derivatives were also tested in experiments and gave the same results than the non-modified peptide).
b)Amphipathic a-helix when bound to membranes
doi:10.1371/journal.pone.0000201.t001
Figure 1. Projections of a–helices of the six basic studied peptides. Basic
residues in black, hydrophobic residues in red, other residues in blue.
The structure of SP associated to membranes is not known. pAntp is
only ,70% helical when interacting with membranes. The basic/
hydrophobic surfaces ratio of RL16 is higher than that of RW16. Helices
were generated with the Swiss-PdbViewer programme.
doi:10.1371/journal.pone.0000201.g001
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Membrane Effects of Peptides
PLoS ONE | www.plosone.org 2 February 2007 | Issue 2 | e201RESULTS
Membrane deformations induced by peptides on
giant unilamellar vesicles
To study the peptide-induced mesoscopic deformations of
membranes by basic peptides, we prepared giant unilamellar
vesicles (GUVs: PC/PG (9/1)). Six peptides were studied. The
neuromodulator substance P (SP), five cell-penetrating peptides,
two mainly basic: Polyarginine (R9), and Penetratin (pAntp), and
three amphipathic: polyarginine-tryptophane (RW16 and RW9)
and polyarginine-leucine (RL16) (table 1 and figure 1).
The cell penetrating peptides pAntp and R9 showed very
similar effects on GUVs. They induced membrane invaginations
in the form of micro-tubes that grow inside vesicles (Fig. 2). The
tubes are able to move inside the vesicles. The growing micro-
tubes invade the entire vesicle internal volume in less than
20 minutes (Video S1). Although we did not quantify tubes, R9
seems to form more numerous tubes than pAntp with a higher
‘‘filling’’ rate (compare panels B versus C, D of figure 2). The
evolution of tubes showed that vesicle integrity was maintained
and that usually, the larger diameter tubes came from a process of
thin tubes enlargement (Video S2). Moreover, these peptides were
able to induce the adhesion of adjacent membranes when vesicles
were initially in close contact (Video S3).
The peptide RW16 exhibited a different behaviour. Indeed,
tubes were also observed for RW16 with the same dynamics for
growth and mobility than for R9 and pAntp peptides. However,
tubes induced by RW16 reach more frequently greater diameter
(fig. 3D and Video S4). RW16 is also able to form small lipid
aggregates inside the vesicles corresponding to the bright spots
detected in Fig 3E. This causes a dramatic perturbation to the
vesicle and leads to a gradual reduction of GUV size. RW16
induced also large endosome-like vesicle formation in a single step
without detectable preliminary formation of tubes (fig. 3F). The
frequency of adhesion of adjacent membranes was higher than
with pAntp or R9. Finally, RW16 induced also occasional bursting
of the GUV.
The shorter peptide, RW9 showed effects similar to RW16, R9
and pAntp. As shown in fig 3A and 3B, thin and large tubes, small
lipid aggregates and endosome-like vesicles coexist in the same
GUV with frequent adhesions. GUVs integrity was not altered by
the peptide and all the membrane fragments are enclosed moving
inside the vesicle. Moreover, as RW16, RW9 also induces vesicle
formation (fig. 3F). It was observed that some vesicles were formed
by fluctuations at the level of adhering membranes.
Amphipathic peptide RL16 induces complete GUV destruction
after few seconds (fig. 3G,H,I). In contrast with other peptides,
Substance-P did not perturb GUVs morphology even after
6 hours of incubation at high peptide concentration (50 mlo f
peptide solution at 0.5 mM in 2 ml of buffer) (not shown). A
summary of results is presented in table 2.
Two phenomena were considered for further studies: 1)
Adhesion of adjacent membranes (this property may be related
to stabilization and modulation of tube diameter) and 2)
membrane permeabilization, which would be responsible for
GUV bursting.
Peptides induce changes on membrane lipids
organization
Tube formation could be a result of peptide-induced membrane
negative curvature. In agreement with this hypothesis, it has been
shown that amphipathic peptide orientation is modulated by the
lipid capability to favour a positive or negative curvature [30] (i.e.
the increase in phosphatidylethanolamine, which induces negative
curvature increases the critical amphipathic peptide concentration,
needed for pore formation). Moreover, this phenomenon was
suggested to be related to bilayer thickness variations but it is still
controversial whether amphipathic peptides thin down [31,32] or
thicken [33] membranes. Moreover, as far as we know, effects of
basic CPPs on model membranes have not been studied by Small
Angle X ray Scattering (SAXS). Therefore, we investigated the
effect of the six peptides on the arrangements of the membrane
bilayer lipids by SAXS. This technique is adapted to the
measurement of the bilayer thickness and to the detection of
highly curved non lamellar lipid arrangements such as cubic or
hexagonal phases [34]. All samples were fully hydrated in order to
avoid any artefactual thinning effects [33]. Figure 4A shows that
PC/PG (9/1) multilamellar vesicles present two separated lamellar
phases with different d-spacings (Ld1 and Ld2). The temperature
dependent behaviour of the samples and the wide-angle scattering
(not shown) showed that the two phases are in the liquid
disordered state (Ld) [35]. The peptides were co-solubilised with
the lipids so the peptide is stacked between the bilayers at
a Peptide/Lipid ratio of 1/20 (w/w). The highly cationic peptide
R9 inhibited the membrane heterogeneity in favour of a unique
liquid disordered phase (fig 4A). The other five peptides kept the
heterogeneity. Moreover, except for SP, which showed a weak
diffraction corresponding possibly to a non lamellar phase, the
other peptides did not induce any transitions to a non lamellar
phase within this particular membrane composition (PC/PG; 9/
1). In figure 4A, it is clear that the peptides changed the position of
the maxima indicating either a modification of the diffraction
repeat distances or a modification in the relative contribution of
the two phases. Because the diffraction peak intensities reflect not
only the amount of the phase-forming lipids but also the form
factor we calculated the electron density profiles from the
diffractogram of each lamellar phase. As noted in table 3, we
Figure 2. Membrane deformations on GUVs (PC/PG 9/1) induced by two
CPPs. Tubular structures observed in vesicles incubated with R9 peptide
(A, B), and pAntp (C, D). Phase contrast microscopy at 25uC. Scale bar
20 mm.
doi:10.1371/journal.pone.0000201.g002
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PLoS ONE | www.plosone.org 3 February 2007 | Issue 2 | e201observed differences of membrane and water layer thickness in the
presence of peptides. Significant thinning was observed on the Ld1
phase for RW9 and SP (Fig 4B). The bilayer thickness was
decreased by both peptides (22.7 and 22.8 A ˚, respectively).
Significant changes were also observed for RL16 on the Ld2 phase
(fig 4C). RL16 induced an increase of +1.3 A ˚ of the membrane
thickness and +1.7 A ˚ in the hydration layer.
Peptides induce membrane adhesion and vesicles
aggregation
In order to quantify peptides ability to provoke membranes
adhesion we measured the aggregation of PC/PG (9/1) large
unilamellar vesicles (60–100 nm LUVs) by monitoring the
turbidity of the sample. As shown in fig 5A, Substance-P that
showed no effect on GUVs does not aggregate LUVs. R9 and
pAntp show similar aggregation profiles consisting of an increase
of aggregation to reach a plateau value. R9 started to aggregate
LUVs at a peptide/lipid mass ratio (P/L) of 1/80 and reached the
plateau at 1/45. pAntp needs higher peptide concentrations and
started to aggregate LUVs at P/L ratio of 1/25 with a plateau at
1/15.
Amphipathic peptides RW9, RW16 and RL16 exhibit a peak-
like profile. The small peptide RW9 showed a large peak for
aggregation starting at P/L 1/35 followed by a decrease at P/L of
1/10. RW16 and RL16 showed sharper peaks starting LUV
aggregation at P/L ratio around 1/25 and a decrease at P/L ratio
of 1/10.
To study these differences between the amphipathic and non-
amphipathic peptides, we analyzed the changes in tryptophan
fluorescence of pAntp, RW16 and RW9 at different P/L ratios.
Table 2. Morphological effects of peptides on giant
unilamellar vesicles (GUVs)
a
......................................................................
Peptides
Effects
on GUVs pAntp R9 RW9 RW16 RL16 SP
Thin tubes ++ + + + + /2 +/22
Large tubes/vesicles +++ +++++ +++++ ++ 22
Adhesion + ++ +++ ++ 22
Burst 22+/2 ++ + 2
a)The quantification of effects was obtained by observation of 153 recorded
GUVs. The number of GUVs containing the different structures and adhering
to other GUVs was counted, however the number of tubes or vesicles induced
by the peptides was not measured due to the frequent high density of
structures inside the vesicles. The evolution of fines tubes to large tubes and
vesicles increases the difficulty to quantify precisely the proportion of
structures.
doi:10.1371/journal.pone.0000201.t002
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Figure 3. Membrane deformations on GUVs (PC/PG 9/1) induced by amphipathic peptides. Coexistence of tubes and small vesicles inside the GUVs
(A, B) and adhesion of GUVs by RW9 (C). Tubes formation (D) membrane aggregates (E) and GUVs adhesion and internal vesicles (F) induced by RW16
peptide. Time-lapse sequence of a GUV burst induced by RL16, t=0 s (G) t=2 s (H) and t=3 s (I). Scale bar 10 mm.
doi:10.1371/journal.pone.0000201.g003
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PLoS ONE | www.plosone.org 4 February 2007 | Issue 2 | e201When tryptophan residues move from a polar to a less polar
environment, the fluorescence emission shifts to lower wavelength
indicating lipid binding (from 356 nm to 344 nm for our peptides)
(see also [36]). In figure 5B, we show that the three peptides are
completely bound to membranes at low P/L ratio. The saturation
for pAntp and RW16 was found at a P/L ratio of 1/10, and for
RW9 at 1/15. The maximal shift in wavelength (peptide-
membrane saturation) correlated with maximal aggregation. At
higher P/L ratios, the wavelength shift decrease indicating the
presence of non-bound peptide. At saturation, pAntp did not
change its capacity to aggregate LUVs but, on the contrary, for the
amphipathic peptides RW16 and RW9, saturation of the
membranes with the peptides blocked LUV aggregation (Fig 5B).
This was interpreted as a change in peptide organisation at the
membrane surface that results in peptide arrangement competent
for pore forming and non-competent with aggregation (see
discussion).
Membrane permeability and cell toxicity
The size reduction and collapse of GUVs incubated with RL16
and to a lower extent with RW16 suggested the capability of
amphipathic peptides to permeabilize membranes. Permeability
was first followed by calcein release from LUVs. Permeabilization
of the membrane results in calcein release, dilution, and
fluorescence increase. As shown in figure 6 and table 4, only
peptide RL16 was able to induce a significant calcein release from
LUVs at a P/L ratio of 1/5.
Cell permeability was also analyzed in Annexin 2-GFP
transfected MDCK cells. Annexin 2 is a Ca
2+-dependent
membrane binding protein. We took advantage of this property
to observe the rise of intracellular Ca
2+ concentration provoked by
the influx of ions through the peptide-permeabilized plasma
membrane by monitoring the fluorescent GFP-protein binding to
the plasma membrane. Cells were incubated with different peptide
concentrations. pAntp, SP, R9 and the short amphipathic peptide
RW9 did not induce any increase in permeability towards ions
even at high peptide concentration (100 mM) (fig 7B and data not
shown). By contrast, the two long amphipathic peptides RW16
and RL16 (10 mM) provoked the Ca
2+ influx and the subsequent
mobilization of annexin 2 from cytosol to the plasma membrane in
10 minutes (fig 7D, 7F and Video S5). In absence of extracellular
Ca
2+ no Annexin 2-GFP movement was detected (not shown). The
comparison of the behaviour of RL16 and RW16 in calcein
leakage from LUVs and Ca
2+ permeability in cells indicates that
the ‘‘pores’’ formed by both peptides are different.
Excessive permeabilization or other membrane perturbations
could induce cell toxicity. We therefore measured cell toxicity on
CHO cells after 48 hours of peptide incubation. As shown in
table 4, the only toxic peptide was RL16.
Figure 4. Membrane thickness alteration induced by peptides. A)
Diffractograms of PC/PG (9/1) MLVs in the absence or presence of
peptides with a weight ratio peptide/lipid of 1/20 (at 20uC). Thick arrow
shows the position of a weak non lamellar contribution induced by
substance P. Ld1 and Ld2 are two lamellar phases clearly distinguished
by slightly different d-spacings. B) Electron density profiles of Ld1 phase
of peptide free MLVs or formed in the presence of RW9 and SP
peptides. C) Electron density profiles of Ld2 phase of peptide free MLVs
or formed in the presence of RW16 and RL16.
doi:10.1371/journal.pone.0000201.g004
Table 3. Effect of the peptides on the thickness of the
membrane bilayer (dbilayer) and hydration layer (dwater) of the
two distinct lamellar phases (Ld1 and Ld2) comprised in the
PC/PG (9/1) multilamellar vesicles at 20uC.
......................................................................
PC/PG pAntp RW9 RW16 RL16 SP
Ld1 Ld2 Ld1 Ld2 Ld1 Ld2 Ld1 Ld2 Ld1 Ld2 Ld1 Ld2
S
21 (nm) 6.13 5.81 6.06 5.94 5.96 5.74 6.08 5.89 6.20 6.01 5.96 5.75
dbilayer (nm) 3.90 3.62 3.78 3.63 3.63 3.55 3.83 3.71 3.93 3.75 3.62 3.54
dwater (nm) 2.23 2.19 2.28 2.31 2.33 2.19 2.25 2.18 2.27 2.26 2.34 2.21
doi:10.1371/journal.pone.0000201.t003
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PLoS ONE | www.plosone.org 5 February 2007 | Issue 2 | e201DISCUSSION
The characterization of peptides-membranes interactions is
fundamental to understand the pathways of peptide internalization
and their effect on membrane permeability. In this work, we
compared six different peptides using complementary approaches
in model membranes and living cells. The use of liposomes is
adapted to study the influence of physico-chemical parameters
such as lipid composition or membrane curvature and living cells
allow an approach with a biological complex membrane. The six
studied peptides showed different behaviour on giant vesicles. We
have previously reported that the primary amphipathic peptide SP
interacts strongly with phospholipids organized either in phospha-
tidylcholine/phosphatidylserine monolayers or small unilamellar
vesicles (SUV) [4]. The electron density profiles of small angle X
ray diffraction of the PC/PG lamellar phases performed in this
study also showed a strong peptide-lipid interaction. Indeed, SP
and RW9 led to the most important decrease of the bilayer
thickness. However, SP showed no effect in all other experiments
performed suggesting that it remains inserted in PC/PG LUV and
GUV bilayers without disturbing the local supra-molecular
organization of lipids. This is probably related to the low number
of positive charges of the peptide (only 3 positive charges within 11
residues) and to shape complementarities between the peptide and
the phospholipids.
The other peptides induced different types of effects on PC/PG
liposomes. Membrane tubulation, adhesion, vesiculation or
bursting were observed with GUVs. The peptides also caused
LUV aggregation or permeabilization. The behaviour of these
peptides bearing at least seven positive charges could be explained
by the different models of lipid-peptide interaction presented in
figure 8, which include the previously reported toroidal pore
model [9]. The different effects observed on the membrane
seemed to be related to the peptide degree of amphipathicity. For
simplification, only the two limit classes of basic non amphipathic
and amphipathic peptides were considered in figure 8.
Figure 5. Membrane bridging capacity of peptides. A) Aggregation
profiles of PC/PG (9/1) vesicles at different Peptide/Lipids weight ratios:
R9 (#), pAntp (%), RW9 ($), RW16 (&), RL16 (m) and SP (X). Optical
density (OD) was recorded at the plateau of aggregation (20 min after
peptide addition). B) Membrane binding and aggregation of RW16,
RW9 and pAntp peptides. Shift in emission wavelength (l shift) in
function of P/L ratio (solid lines). LUVs aggregation (dotted lines). For
presentation facility, data were adjusted in arbitrary units. pAntp (%),
RW9 ($), RW16 (&). All experiments were achieved at 25uC.
doi:10.1371/journal.pone.0000201.g005
Figure 6. Peptide-induced LUVs permeability at different Peptide/Lipid
weight ratio. Percent of calcein release from LUVs 5 min after peptide
addition: R9 (#), pAntp (%), RW9 ($), RW16 (&), RL16 (m) and SP (X).
Experiments were achieved at 25uC.
doi:10.1371/journal.pone.0000201.g006
Table 4. Membrane permeabilization and cell toxicity of
peptides.
......................................................................
pAntp R9 RW9 RW16 RL16 SP
Calcein release
a 11% 8% 7% 14% 38% 8%
Cell permeabilization
b no no no yes yes no
Lethality
c 00 0 05 5 % 0
a)Percent of calcein released from LUVs at a peptide/lipid ratio of 1/2
b)Monitored by calcium permeability inducing annexin 2 movement in MDCK
cells
c)After 48 hours of incubation of CHO cells with 10 mM peptides
doi:10.1371/journal.pone.0000201.t004
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PLoS ONE | www.plosone.org 6 February 2007 | Issue 2 | e201The amphipathic peptide RL16 may bind membranes by two
types of interactions: the electrostatic interaction of basic residues
with negatively charged phosphate groups of phospholipids and by
hydrophobic residues with the fatty acyl chains of the bilayer. If
this ‘‘snorkelling’’ effect is strong and able to induce a lipid
rearrangement between the two membrane leaflets, the peptides
allow positive curvature on the membrane (fig 8B). This model is
similar to that suggested by Mangavel [37] for the amphipathic
peptide KL20. This peptide lies parallel to the plane of the bilayer
of Small Unilamellar Vesicles. The authors suggest that the
phospholipid headgroups protrude from the bilayer towards the
solvent due to electrostatic interactions with the amino groups of
the peptide. This favours membrane aggregation and modifies
membrane thickness. We showed that RL16 induces a significative
increase of the bilayer thickness. This increase may be related to
the protrusion suggested for the phospholipid headgroups and may
be important for membrane permeabilization. Two models of
permeation mechanisms have already been proposed: i) the barrel-
stave model in which the amphipathic peptides aggregate and
insert into the lipid bilayer with the hydrophobic amino acid
residues intercalated between the lipids and the hydrophilic faces
forming the inside wall of the pore. In this model, the peptide is
long enough to span the bilayer. ii) The toroidal model or
detergent-like mechanism in which the peptide interacts with
phospholipid headgroups on the membrane surface and curves
strongly the bilayer so the pore is lined by headgroups associated
with peptides. In this case, short peptides not long enough to span
the membrane are able to form lipoproteic pores. [9–13]. RL16,
which induces formation of ‘‘pores’’ is able to release widely
calcein from LUVs, provokes massive GUVs burst, permeabilize
and kill cells. In contrast, RW16 seems to form smaller pores since
it is able to induce calcium permeabilization of cell membranes
and occasional GUV burst but does not induce calcein release
from LUVs. RL16 increases membrane thickness by 1.3 A ˚ and
RW16 by only 0.9 A ˚. For RL16 and RW16 peptides, ‘‘solvation’’
could generate transient effects on the membrane structure leading
to toroidal-like pores (fig 8C). Both peptides must be able to recruit
phospholipids differently depending on their charges to optimise
shape complementarities. In support of the proposed membrane
positive curvature induced by amphipathic peptides, it was shown
that lysoPC, a lipid with positive curvature tendency, facilitate the
formation of toroidal pores by alameticin and melitin [10,30].
RL16 induced essentially the bursting of giant vesicles. This result
is similar to a previous study showing that ‘‘short’’ amphipathic
antimicrobial sequences, citropein and aurein (16 and 15 residues
respectively) induced the complete and immediate destruction of
GUVs [38]. Like citropein and aurein, RL16 is not long enough to
span the membrane. Therefore, the detergent-like mechanism is
a simple assumption to explain GUVs destruction. However, it
does not seem only related to peptide length, hydrophobicity and
basic surface extension ratio appear to be crucial since RW16 with
the same length does not cause such dramatic effect on GUVs.
The hydrophobic indexes decrease from Leu (3.8), Trp (20.9) to
Arg (24.5) [39] suggesting that the average orientations of
peptides must differ between RL16 and RW16. Tryptophans are
generally located at the water membrane interface. In summary,
its permeabilization power is smaller than that of the RL16
peptide. The explanation is based on the weaker detergency power
of the peptide due to the more symmetric distribution of charged
and hydrophobic surfaces of the a-helix of RW16 compared to
RL16 (fig 1).
For the basic non-amphipathic peptides, where the positive
charges are not segregated on a particular area of the helix
circumference, membrane binding must be essentially due to
electrostatic interactions of basic residues with phosphates. In our
model, the recruitment of phospholipids without important
snorkelling and low or no phospholipid protrusion would result
in negative curvature-competent membrane asymmetry (fig 8D).
This binding could also be responsible for membrane aggregation
by peptides bridging simultaneously two membranes (fig 8E). The
presented X ray diffraction data indicated that SP and RW9
reduced the bilayer thickness. Since SP showed no effects in our
experiments and R9 and pAntp showed slight changes of bilayer
thickness, we assume that this membrane perturbation is not
sufficient to explain tubes formation or membrane aggregation.
The basic residues in the surface must be in the right positions (i.e.
in all directions) to induce membrane aggregation.
Figure 7. Movement of Annexin 2-GFP by peptide-induced ion
permeabilization of the plasma membrane. Visualisation by fluores-
cence microscopy of the Anx2-GFP migration from the cytsol to the
plasma membrane before and after addition of peptides (10 mM).
pAntp, RL16 and RW16. (A,C,E before peptide addition, B,D,F 10 min
after peptide addition). Scale bar 10 mm.
doi:10.1371/journal.pone.0000201.g007
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membranes are quite stable for the non-amphipathic R9 and
pAntp peptides. In contrast, the amphipathic peptides showed
blockage of aggregation when increasing the P/L ratio. The
correlation between the experiments of turbidity and fluorescence
maxima shift obtained with RW9 and RW16 peptides indicates
that when these peptides reach the surface saturating concentra-
tion, they change their conformation and/or peptide-peptide
interactions. At this stage, the peptides may not induce
aggregation but provoke ‘‘pore’’ formation. This is in agreement
with Huang’s group results showing that when helical peptides
reach a threshold concentration (P/L*) they switch from a parallel
to a perpendicular orientation to the plane of the bilayer, this
induces formation of pores [10]. This last hypothesis is supported
by the fact that RL16 peptide induces calcein leakage from LUVs
at the same P/L ratio at which it blocks LUV aggregation. On the
contrary, for pAntp peptide the increase of P/L ratio after
membrane saturation results in a very low decrease of aggregation
suggesting a more stable peptide-lipid interaction. This low
decrease can be explained by the conformational change of
membrane bound pAntp. At low peptide/lipid ratio pAntp adopts
a partially a-helical structure [19], at high peptide/lipid ratio and
high PG content the a-helix shifts to a b-structure [20,21,40–42].
As stated by Persson [43], it is difficult to know whether
aggregation induces the pAntp conformational transition from
a–helix to b–sheet or vice versa. Based on experiments with PEG-
conjugated lipids the authors found that the transition is driven by
membrane aggregation, which is consistent with our model in
which the a–helix induces the membrane adhesion. A further
conformational change (b–sheet transition) could explain mem-
brane breaking apart and tube enlargement for pAntp.
Considering the tubes formation by non amphipathic peptides,
and in agreement with our data, it was reported that polylysine
induces the formation of membrane tubes in GUVs [44]. Tubes
formation could be a consequence of the lipid asymmetry induced
by the peptides (fig 8F). The starting driving force for tubulation
would be based on the phospholipid asymmetry between inner
and outer layers which generates invagination [45,46]. In model
membranes, the two leaflets are symmetric and therefore the
surface tension is nil and no budding should occur. Our hypothesis
is that highly positively charged CPPs such as R9 or pAntp recruit
lipids on the outer monolayer. This process generates a local
asymmetry so that the outer layer is compressed and the inner is
relatively dilated. In agreement with GUVs experiments, the
model predicts that the invagination grows in the form of tubes
inside the vesicles. This driving force would be stabilized further by
the capability of peptides to bridge membranes. This results in the
formation of thin tubes observed for R9, pAntp and RW9. As
proposed by Gonc ¸alves et al. [47], membrane adhesion could also
be powered by intervesicle peptide bridges. Thus, the membrane
bridging property of peptides could stabilize tube growth. It is
interesting to note that the R9 and RW9 tubes often remain thin
Figure 8. Model for peptide-membrane interaction. A) Two main properties are considered: amphipathicity and net positive charge. Changes in these
properties result in different degrees of membrane perturbations. Basic surface in dark, hydrophobic surface in white. B) The binding of the
amphipathic peptides involves electrostatic interactions between the basic residues and lipid headgroup negative charges, and hydrophobic
interactions with lipid fatty acyl moieties. A strong snorkelling effect of the peptide could induce protrusion of headgroups attracted by the charged
helix residues inducing lipid reorganisation resulting in asymmetry of the bilayer halves and positive curvature of the membrane. C) The detergent
property of amphipathic peptides and the induced positive curvature result in the formation of toroidal pores. D) The binding of basic peptides
mainly involves electrostatic interactions with the lipid headgroup phosphates. This results in the recruitment of phospholipids and then in
membrane asymmetry with negative curvature. E) The bridging interaction of the peptide between two membranes allows adhesion and vesicles
aggregation. F) Membrane tubulation results from the membrane curvature inducing invaginations. The thin tubes could be stabilized by the
bridging properties of the peptides between membranes apposed faces.
doi:10.1371/journal.pone.0000201.g008
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frequently. Moreover, it is difficult to explain all these effects
without cooperativity between peptides. The deformation of the
membrane bilayer and the tubular growth would need the
clusterisation of peptides on the membrane surface. The
clusterisation would be obtained by phospholipids bridging basic
residues of adjacent peptides (Fig. 8F). This property is apparently
not related to the amphipathicity of the peptide and seems to be
more related to the high density of positive charges present in the
peptides. LUV’s aggregation is correlated with the GUVs
tubulation. Peptides efficient for tubulation such as R9, RW9
and pAntp are also able to aggregate LUVs efficiently at the
lower Peptide/Lipid ratios (1/50, 1/30 and 1/20 respectively,
figure 5).
In conclusion, we have established that a combination of the
number of basic residues and their relative position is important
for membrane perturbations. The non-amphipathic basic peptides
are able to induce membrane aggregation and tube formation but
do not form pores and show low cell toxicity. The amphipathic
peptides are able to form tubes and bridges and permeabilize
membranes (pores). However, the properties of the amphipathic
peptides are widely modulated by their length (the short peptide
RW9 seems not to form ‘‘pores’’) and the distribution of charged
versus hydrophobic residues at the surface of the helix gives to the
peptides different degree of detergent character and then different
pore forming efficiency.
The model of lipid-peptide interaction illustrated in figure 8
sketches the behaviour of two archetypal peptides. pAntp, which
does not adopt a perfect amphipathic helix, has an intermediate
behaviour and seems to associate to membranes with a certain
degree of snorkelling [48].
The different degree of toxicity of amphipatic peptides may be
explained by different toroidal pore sizes as showed by the
differences in the toxicity of RW16 and RL16. Many models were
proposed to explain CPPs cellular uptake: direct membrane
penetration, inverted micelle formation [17], or different endocy-
totic pathways [14,16]. The absence of molecular explanations for
the energy-independent steps in the cell uptake results in
controversial data [18]. For the cell penetrating peptides, tube
formation could be another important pathway for penetration
into cells. Interestingly, the formation of tubular structures can
account for the metabolic energy-independent internalization of
peptides, which has been a subject of debate. In fact, this capacity
of basic domains to invaginate membranes in a ‘‘physical’’
endocytosis-like way would be one of the first steps of cell
internalization before the final translocation to the cytosol of basic
penetrating peptides. It will be interesting to explore the possibility
of this mechanism as a new and general pathway of internalization
of proteins such as the proteins with transduction domains,
homeoproteins, Tat and toxins.
MATERIALS AND METHODS
Materials
Egg yolk L-a-Phosphatidylcholine (PC), egg yolk L-a-Phosphati-
dyl-DL-glycerol (PG) and calcein were purchased from Sigma. l-3-
Phosphatidylcholine,1-palmitoyl-2-[1-
14C]palmitoyl ([
14C] PC )
was obtained from Amersham. Standard tertiobutyloxycarbonyl
(Boc) amino acids, p-methylbenzhydrylamine-polystyrene resin,
and O-(benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluoro-
phosphate (HBTU) were purchased from Senn Chemicals
(Dielsdorf, Switzerland). Solvents (peptide synthesis grade) and
other reagents for peptide synthesis were obtained from Applied
Biosystems.
Peptide Synthesis
Peptides were assembled by solid-phase synthesis on an ABI
Model 433A peptide synthesizer (Applied Biosystems) using
a standard Boc strategy (amino acid activation with dicyclohex-
ylcarbodiimide/1-hydroxybenzotriazole or HBTU). Peptides were
cleaved from the resin by treatment with anhydrous HF (1 h, 0uC)
in the presence of anisole (1.5 ml/g peptidyl resin) and dimethyl
sulfide (0.25 ml/g peptidyl resin). Peptides were purified by
preparative reverse-phase HPLC on a C8 column, using a linear
acetonitrile gradient in an aqueous solution of 0.1% (v/v)
trifluoroacetic acid. Peptides were .95% pure as assessed by
analytical HPLC. Peptide identity was checked by MALDI-TOF
mass spectrometry (Voyager Elite, PerSeptive Biosystems) using
cyano-4-hydroxycinnamic acid matrix.
Preparation and visualisation of giant vesicles
Giant unilamellar vesicles (GUVs) were obtained by electroforma-
tion as described in [49]. Briefly, 1.5 ml of PC/PG (9/1, w/w)
solution (0.4 mg/ml in chloroform/methanol 9/1) were spread on
each platinum electrode. The lipid film was dried for half an hour
under a gentle stream of nitrogen. The chamber was placed in an
inverted microscope (Zeiss Axiovert 200M) and a thermocouple
positioned to monitor the temperature (25uC). The electrodes were
then completely hydrated with 2 ml of a low ionic strength buffer
(HEPES 0.5 mM, pH 7.4 and conductivity 20 mS/cm). Immedi-
ately after buffer addition, a low frequency alternating field (5 Hz
and 1 V) was applied on the electrodes for at least 2 hours. GUVs
of diameter between 10 to 100 mm were observed. 2.5 mlo f
50 mM peptides solution were added close to the electrodes (2 ml
of buffer) and images were captured with a CCD camera (Cool
SNAP HQ) controlled with Metamorph software (Roper Scien-
tific). The observation temperature was 25uC.
Preparation of LUVs and calcein-loaded LUVs
Large unilamellar vesicles (LUV) were prepared by extrusion
through a polycarbonate filter (pore diameter 100 nm) in an
extrusion device from Avestin as described in [38]. To obtain
calcein loaded LUVs, at 2 mg/ml lipid concentration (PC/PG/
[
14C] PC 9/1/0.01 mol ratio), a solution in chloroform was dried
under a gentle stream of nitrogen and maintained under vacuum
for at least 2 h to ascertain removal of residual solvent. Then, the
dried lipid film was hydrated with 1 ml of 70 mM calcein solution
in HEPES 10 mM pH 7.4, vigorously vortexed and extruded.
Free calcein was separated by passing the suspension trough two
gel filtration columns in tandem (Econo-Pac 10 DG, Bio-Rad).
The final lipid concentration was quantified measuring the [
14C]
PC radiactivity with a liquid scintillation counter LS 6000 SC
(Beckman Coulter France).
Membrane aggregation
LUVs aggregation was monitored by turbidimetry (absorbance at
340 nm) in a Cary spectrophotometer (Varian) as described [50].
Peptides were added to a 500 ml quartz cuvette containing 10 mg
of LUVs in a HEPES 10 mM pH 7.4 buffer and the absorbance
was followed during 20 min after peptide exposure. At this time,
membrane aggregation attained the plateau.
Measure of calcein leakage from LUVs
The release of calcein after 5 minutes of peptide exposure to
LUVs was measured by spectrofluorimetry (Varian eclipse) at
excitation and emission wavelengths of 490 nm and 500–650 nm,
respectively. The spontaneous leakage of calcein in absence of
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PLoS ONE | www.plosone.org 9 February 2007 | Issue 2 | e201peptide was found to be negligible. Leakage was expressed as
a percent relative of the total amount of dye released by LUVs lysis
with 1% Triton X-100, according to equation: % relea-
se=1006(F(t)2F0)/(FT2F0). F(t) is the fluorescence intensity at
time t, F0 is the fluorescence intensity before peptide addition and
FT the fluorescence intensity after LUVs lysis.
Tryptophan fluorescence
Tryptophan fluorescence was measured following the recommen-
dations described in [51]. Excitation wavelength was 280 nm, and
emission spectrum was collected (290–600 nm). Excitation and
emission slits were 6 nm and 5 nm respectively. A cross-oriented
configuration of the polarizer (Expol=90u,E m pol=0u) was used in
order to reduce LUVs diffusion artefacts.
X-ray diffraction
Small-angle X-ray scattering (SAXS) measurements were per-
formed at stations 8.2 and 16.1 of the Daresbury Synchrotron
Radiation Laboratory (UK) following a protocol adapted from
Tessier et al. [52]. Briefly, samples for SAXS examination were
prepared by dissolving dry lipids in chloroform/methanol (2/1,
vol/vol) and mixing to obtain the indicated proportions. The
solvent was subsequently evaporated under a stream of oxygen-
free dry nitrogen at 45uC and traces of solvent removed by
a storage under high vacuum for 2 days. In order to obtain the
Multiple Lamellar Vesicles (MLVs) the dry lipids were hydrated
with an equal weight of buffer (5 mM HEPES pH 7.4). The
aqueous lipid dispersion was thoroughly stirred to obtain
a homogeneous dispersion, sealed under argon and kept until
examination at 4uC. For X-ray measurements, lipid samples
(,20 ml) were deposited between two thin mica windows and
mounted on a programmable thermal stage (Linkam, UK). The
temperature was monitored by a thermocouple (Quad Service,
Poissy, France) inserted directly into the lipid dispersion. Samples
were exposed for 30 seconds to the beam (1.5 A ˚ wavelength). The
SAXS quadrant detector response was corrected for the uneven
channel response using a static radioactive iron and S was
calibrated for d-spacing using hydrated rat tail collagen. In-
formation on the setup, calibration, and facilities are available on
the station web site (http://www.srs.dl.ac.uk/ncd/station82/de-
scription.html).
The electron density profiles of lipid bilayers were obtained by
Fourier synthesis of x-ray diffraction patterns [53]. Integrated
densities were derived from five diffraction orders (estimated
spatial resolution ,0.12 nm) by measuring the area under each
diffraction peak separated and integrated using the software
Peakfit (Seasolve).
Cell permeability and cell toxicity assays.
Annexin 2-GFP expression vector was a kind gift of Dr Stephen
Moss (London UK). The annexin2-GFP transfected MDCK
cloning will be published elsewhere. MDCK cells were cultured as
described [54]. Peptides were added at different concentrations
and the annexin-GFP fluorescence was followed in a Zeiss inverted
microscope. Films were acquired with Metamorph software.
Cytotoxicity in CHO cells was evaluated using the CCK8 cell
counting kit (Dojindo Laboratories). Briefly, cell suspension
(100 ml, 1500 CHO cells per well) were seeded in DMEM plus
10 % FCS in 96-well microtiter plate at 37uC. 10 ml of peptides
were added twice to the cells after 24 and 48 hours of cell culture
to obtain concentrations of 1, 10, 20 and 50 mM and the toxicity
was evaluated 48 after treatment.
SUPPORTING INFORMATION
Video S1 Fine tubes formed in GUVs by R9 peptide.
Found at: doi:10.1371/journal.pone.0000201.s001 (1.06 MB
MOV)
Video S2 Start of a growing tube induced by pAntp.
Found at: doi:10.1371/journal.pone.0000201.s002 (1.62 MB
MOV)
Video S3 pAntp induced adhesion of GUVs.
Found at: doi:10.1371/journal.pone.0000201.s003 (0.19 MB
MOV)
Video S4 Growing tubes induced by RW16 peptide.
Found at: doi:10.1371/journal.pone.0000201.s004 (0.99 MB
MOV)
Video S5 Annexin 2-GFP movement from cytosol to the plasma
membrane induced by
Found at: doi:10.1371/journal.pone.0000201.s005 (0.42 MB
MOV)
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